Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
BackgroundAngiotensin II receptor blockers (ARBs) are utilized for the management of hypertension and diabetes. Previous meta-analyses suggested that azilsartan medoxomil (AZL-M) improved blood pressure (BP) reduction, but there were no safety findings or suggestions for patients with hypertension o...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-07-01
|
| シリーズ: | Frontiers in Cardiovascular Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383217/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|